Abstract
The antimycobacterial activity of new 18 7-chloroquinoline derivatives, obtained from 4,7-dichloroquinoline, was evaluated against 15 Mycobacterium spp among standardized and clinical isolates using the MTT susceptibility test to obtain minimum inhibitory concentration values (MIC, μg/mL). The results suggested that 7-chloroquinoline compounds are useful leads for new anti-TB drug development. The most active compounds exhibited moderate activity with 16 μg/mL MIC values for all tested microorganisms.
Keywords: 7-Chloroquinoline derivatives, Synthesis, MDR-TB, Antimycobacterial activity, Tuberculosis (TB), Mycobacterium tuberculosis, human immunodeficiency virus (HIV), rifampin (RMP), isonicotinylhydrazine, INH, Heterocyclic systems, quinine, chloroquine, primaquine, amodiaquine
Letters in Drug Design & Discovery
Title: In Vitro Antimycobacterial Activity of New 7-Chloroquinoline Derivatives
Volume: 9 Issue: 2
Author(s): Juan Bueno, Fernando A. Rojas Ruiz, Santiago Villabona Estupinan and Vladimir V. Kouznetsov
Affiliation:
Keywords: 7-Chloroquinoline derivatives, Synthesis, MDR-TB, Antimycobacterial activity, Tuberculosis (TB), Mycobacterium tuberculosis, human immunodeficiency virus (HIV), rifampin (RMP), isonicotinylhydrazine, INH, Heterocyclic systems, quinine, chloroquine, primaquine, amodiaquine
Abstract: The antimycobacterial activity of new 18 7-chloroquinoline derivatives, obtained from 4,7-dichloroquinoline, was evaluated against 15 Mycobacterium spp among standardized and clinical isolates using the MTT susceptibility test to obtain minimum inhibitory concentration values (MIC, μg/mL). The results suggested that 7-chloroquinoline compounds are useful leads for new anti-TB drug development. The most active compounds exhibited moderate activity with 16 μg/mL MIC values for all tested microorganisms.
Export Options
About this article
Cite this article as:
Bueno Juan, A. Rojas Ruiz Fernando, Villabona Estupinan Santiago and V. Kouznetsov Vladimir, In Vitro Antimycobacterial Activity of New 7-Chloroquinoline Derivatives, Letters in Drug Design & Discovery 2012; 9 (2) . https://dx.doi.org/10.2174/157018012799079761
DOI https://dx.doi.org/10.2174/157018012799079761 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress in Structure-Based Design of EGFR Inhibitors
Current Drug Targets Liposome-Nanogel Structures for Future Pharmaceutical Applications
Current Pharmaceutical Design Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Despite an Extensive Sequence Analysis Identification of Functional Candidates Amongst Hypothetical Proteins of Neisseria gonorrhoeae
Letters in Drug Design & Discovery Recent Synthesis of Marine Natural Products with Antibacterial Activities
Anti-Infective Agents in Medicinal Chemistry QSAR Multi-Target in Drug Discovery: A Review
Current Computer-Aided Drug Design Stopping of the Downtrend of Tuberculosis in Iran, a Systematic Review of Associated Risk Factors
Infectious Disorders - Drug Targets Proteomic analysis of a <i>hom</i>-disrupted, cephamycin C overproducing <i>Streptomyces clavuligerus</i>
Protein & Peptide Letters Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry 4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Medicinal Chemistry of New Compounds to Treat Tuberculosis
Current Clinical Pharmacology Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Synthesis of Cross-linkable 2,5-Diketopiperazine Derivatives
Letters in Organic Chemistry Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants
Anti-Infective Agents A Computational Study of Molecular Interactions and In Vitro Antibacterial Activity of 6-Substituted Quinoline Carboxylic Acid Derivatives as DNA Gyrase Inhibitors
Letters in Drug Design & Discovery Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Extrapulmonary Sarcoidosis: A Chameleon Disease at Imaging
Current Medical Imaging HIV Infection Late Detection in AIDS Patients of an European City with Increased Immigration Since Mid 1990s
Current HIV Research Promising Drugs Against Tuberculosis
Recent Patents on Anti-Infective Drug Discovery Crucial Enzymes in the Hydroxylated Triacylglycerol-ricinoleate Biosynthesis Pathway of Castor Bean
Current Protein & Peptide Science